Emerson Electric Posts Strong Q3 Sales Growth, Updates 2024 Outlook
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 07 2024
0mins
Should l Buy EMR?
Source: Benzinga
Financial Performance: Emerson Electric Co reported a third-quarter FY24 net sales growth of 11% year-over-year to $4.38 billion, surpassing expectations, with adjusted EPS improving by 11% to $1.43. The company also declared a quarterly cash dividend of $0.525 per share.
Future Outlook: Emerson revised its FY24 net sales growth outlook to approximately 15%, with underlying sales growth expected at around 6%. The company plans to allocate about $300 million for share repurchases and $1.2 billion for dividends in the upcoming fiscal year.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EMR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EMR
Wall Street analysts forecast EMR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for EMR is 150.46 USD with a low forecast of 125.00 USD and a high forecast of 170.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Analyst Rating
7 Buy
6 Hold
1 Sell
Moderate Buy
Current: 150.940
Low
125.00
Averages
150.46
High
170.00
Current: 150.940
Low
125.00
Averages
150.46
High
170.00
About EMR
Emerson Electric Co. is a global technology and software company that provides solutions for customers in a wide range of end markets around the world. The Company operates through seven segments under two business groups, such as Intelligent Devices and Software and Control. Its Intelligent Devices business includes Final Control, Measurement & Analytical, Discrete Automation, and Safety & Productivity. Software and Control business includes Control Systems & Software, Test & Measurement, and AspenTech. Its Final Control segment is a global provider of control valves, isolation valves, shutoff valves, pressure relief valves, pressure safety valves, actuators, and regulators for process and hybrid industries. Its Measurement & Analytical segment is a supplier of intelligent instrumentation measuring the physical properties of liquids or gases. AspenTech segment provides asset optimization software that enables industrial manufacturers to design, operate and maintain their operations.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, including upgrades, downgrades, and initiations, reflecting varying market perspectives on these stocks.
- Market Focus: Analysts' views on SNAP stock have garnered investor attention, and while specific ratings are not detailed in the report, there remains a divergence in market expectations for its future performance.
- Impact of Rating Changes: The changes in ratings could influence investor decisions, especially in the current market environment where reliance on analyst opinions is heightened, potentially leading to stock price volatility.
- Further Information: For a complete view of all analyst rating changes, including upgrades, downgrades, and initiations, it is recommended to visit Benzinga's analyst ratings page for more comprehensive information and data.
See More
- Analyst Rating Updates: Top Wall Street analysts have adjusted their ratings on several companies, reflecting the latest market sentiment towards these stocks, although specific names were not disclosed, investors should pay attention to these changes for informed decision-making.
- Impact of Rating Changes: Upgrades or downgrades in ratings can directly influence the market performance of the related stocks, prompting investors to closely monitor these shifts to timely adjust their portfolios for optimized returns.
- Market Reaction Expectations: Analyst rating adjustments often trigger immediate market reactions, particularly when investors have a high level of interest in specific stocks, potentially leading to short-term price volatility.
- Information Access Channels: Investors can visit the analyst ratings page to obtain a comprehensive view of rating changes, including upgrades, downgrades, and new initiations, thereby better grasping market dynamics.
See More
- Biotech Investment Recommendation: Jason Snipe, founder of Odyssey Capital Advisors, recommended the iShares Biotechnology ETF (NYSE:IBB) on CNBC, emphasizing the potential for long-term investment in the biotech sector, reflecting confidence in future growth.
- Amcor's Strong Earnings: Amcor plc (NYSE:AMCR) reported second-quarter earnings of $0.86 per share on February 3, beating the analyst consensus of $0.85, although quarterly sales of $5.449 billion fell short of the $5.576 billion estimate, indicating strong profitability.
- Positive Stock Performance: Following the earnings report, Amcor's stock rose by 8.1% to close at $48.56, suggesting a favorable market reaction to its financial performance, which may attract more investor interest.
- Emerson Electric's Better-Than-Expected Results: Emerson Electric Co. (NYSE:EMR) reported first-quarter adjusted EPS of $1.46, exceeding the $1.41 consensus estimate, and raised its FY26 EPS guidance, showcasing ongoing growth potential in the industrial sector.
See More
- Analyst Rating Updates: Top Wall Street analysts have adjusted their ratings on several companies, indicating a shift in market sentiment that could influence investor decisions and market trends.
- Upgrades and Downgrades: The rating changes include both upgrades and downgrades for certain stocks, prompting investors to pay attention to these shifts to assess potential investment opportunities and risks.
- Market Reaction Expectations: Analyst rating adjustments typically trigger immediate market reactions, and investors should closely monitor how these changes impact stock prices to timely adjust their investment strategies.
- Comprehensive Rating View: For a complete overview of all analyst rating changes, including upgrades, downgrades, and initiations, it is recommended to visit the analyst ratings page for detailed data and analysis.
See More
- Tech Stock Decline: Tech stocks have been severely impacted by recent volatility, with AMD's share price plummeting 17% as investor confidence in the enterprise software sector wanes, highlighting the risks of over-reliance on tech investments.
- Strong Performance of Blue-Chip Stocks: In stark contrast to tech stocks, the Dow Jones Industrial Average rose by 260 points, or 0.5%, indicating that old-economy companies are demonstrating greater resilience during market turmoil, attracting investors seeking stability.
- Winners Across Industries: Companies like Campbell, PepsiCo, Smuckers, and Kraft Heinz have seen their stock prices rise despite the threat of GLP-1, reflecting ongoing consumer demand and confidence in the food sector amidst market fluctuations.
- Recovery in Banks and Industrials: Recent gains in bank stocks and industrials such as Honeywell, Dover, and Emerson Electric suggest that investors believe these firms will benefit from efficiency improvements brought by artificial intelligence, enhancing their investment appeal.
See More
- Tech Stock Pullback: Tech stocks have faced significant declines recently, with AMD dropping 17% as investor confidence wanes in the enterprise software sector, highlighting the risks of over-reliance on tech investments.
- Strong Performance in Traditional Sectors: In contrast, the blue-chip Dow Jones Industrial Average rose by 260 points, or 0.5%, indicating that traditional sectors like banking and industrials are attracting investor interest in the current market environment.
- Investment Value in Healthcare: Companies like Johnson & Johnson, Merck, and Amgen have performed well, and despite their stock price increases this year, they are still considered valuable investments relative to the broader market, showcasing the stability and appeal of the healthcare sector.
- Recovery of Banks and Industrials: With growing investor confidence in AI's efficiency improvements, banks and industrial stocks such as Honeywell and Dover have also seen gains recently, reflecting optimistic expectations for these companies' future profitability.
See More











